PBYI

6.11

1.45% -0.09

Handel nachbörslich: 6.11

Puma Biotechnology Inc (PBYI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$6.20

Offen:

$6.1

24-Stunden-Volumen:

322.10K

Relative Volume:

0.68

Marktkapitalisierung:

$307.89M

Einnahmen:

$230.47M

Nettoeinkommen (Verlust:

$30.28M

KGV:

10.02

EPS:

0.61

Netto-Cashflow:

$38.86M

1W Leistung:

+5.89%

1M Leistung:

+10.69%

6M Leistung:

+69.72%

1J Leistung:

+72.11%

1-Tages-Spanne:

$6.08

$6.255

1-Wochen-Bereich:

$5.745

$6.29

52-Wochen-Spanne:

$2.575

$6.29

Puma Biotechnology Inc Stock (PBYI) Company Profile

Firmenname

Puma Biotechnology Inc

Sektor

Healthcare (1115)

Branche

Biotechnology (621)

Telefon

(424) 248-6500

Adresse

10880 WILSHIRE BLVD., LOS ANGELES, CA

Mitarbeiter

172

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

PBYI's Discussions on Twitter

Vergleichen Sie PBYI mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PBYI Puma Biotechnology Inc	6.11	312.42M	230.47M	30.28M	38.86M	0.61
VRTX Vertex Pharmaceuticals Inc	463.86	119.17B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	796.55	84.19B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	398.29	52.77B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	788.49	48.98B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	175.97	36.31B	447.02M	-1.18B	-906.14M	-6.1812

Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-09-28	Hochstufung	Citigroup	Neutral → Buy
2020-06-25	Fortgesetzt	BofA/Merrill	Underperform
2019-10-08	Herabstufung	Goldman	Neutral → Sell
2019-05-10	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2019-05-10	Herabstufung	Citigroup	Buy → Neutral
2019-01-17	Eingeleitet	Leerink Partners	Mkt Perform
2019-01-03	Herabstufung	Guggenheim	Buy → Neutral
2018-11-19	Hochstufung	Goldman	Sell → Neutral
2018-11-02	Herabstufung	BofA/Merrill	Buy → Underperform
2018-11-02	Herabstufung	JP Morgan	Neutral → Underweight
2018-10-01	Eingeleitet	Cantor Fitzgerald	Overweight
2018-09-17	Eingeleitet	Goldman	Sell
2018-05-11	Bestätigt	Stifel	Buy
2017-11-10	Bestätigt	Citigroup	Buy
2017-11-10	Bestätigt	RBC Capital Mkts	Sector Perform
2017-10-02	Bestätigt	Stifel	Buy
2017-09-11	Bestätigt	Credit Suisse	Outperform
2017-07-10	Fortgesetzt	Leerink Partners	Outperform
2017-06-06	Bestätigt	RBC Capital Mkts	Sector Perform
2017-05-25	Bestätigt	RBC Capital Mkts	Sector Perform
2017-03-02	Bestätigt	RBC Capital Mkts	Sector Perform

Alle ansehen

Puma Biotechnology Inc Aktie (PBYI) Neueste Nachrichten

Jan 08, 2026

Will Puma Biotechnology Inc. stock keep outperforming rivalsTrade Risk Report & AI Enhanced Execution Alerts - ulpravda.ru

Jan 08, 2026

Hunt Douglas, SVP at Puma Biotechnology, sells $52,695 in PBYI By Investing.com - Investing.com Nigeria

Jan 08, 2026

Auerbach Alan sells Puma Biotechnology (PBYI) shares worth $204k By Investing.com - Investing.com South Africa

Jan 08, 2026

Hunt Douglas, SVP at Puma Biotechnology, sells $52,695 in PBYI - Investing.com

Jan 08, 2026

Puma biotech CFO Nougues sells $64k in shares - Investing.com

Jan 08, 2026

Auerbach Alan sells Puma Biotechnology (PBYI) shares worth $204k - Investing.com

Jan 08, 2026

Will Puma Biotechnology Inc. stock continue dividend increasesEarnings Trend Report & Reliable Price Breakout Signals - ulpravda.ru

Jan 08, 2026

Jan 07, 2026

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com

Jan 07, 2026

Puma Biotechnology reports inducement awards under Nasdaq Listing Rule 5635(c)(4) - MarketScreener

Jan 07, 2026

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets

Jan 07, 2026

Dec 31, 2025

Up 91% in the Past Year, Is This Biotech Stock Red Hot or a Red Flag? - Yahoo Finance

Dec 31, 2025

Puma Biotechnology (NASDAQ:PBYI) Shares Cross Above 200 Day Moving AverageHere's What Happened - MarketBeat

Dec 31, 2025

Dec 24, 2025

Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference - sharewise.com

Dec 24, 2025

Dec 23, 2025

Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI) - BioSpace

Dec 23, 2025

Dec 22, 2025

Puma Biotechnology Added to Nasdaq Biotechnology Index - marketscreener.com

Dec 22, 2025

Dec 21, 2025

If EPS Growth Is Important To You, Puma Biotechnology (NASDAQ:PBYI) Presents An Opportunity - Yahoo Finance

Dec 21, 2025

Dec 20, 2025

How Puma Biotechnology Inc. stock reacts to oil pricesPortfolio Value Report & Low Risk High Reward Trade Ideas - Улправда

Dec 20, 2025

What dividend safety score for Puma Biotechnology Inc. stockJuly 2025 Momentum & Long-Term Growth Portfolio Plans - Улправда

Dec 20, 2025

Dec 19, 2025

What analyst consensus says on Puma Biotechnology Inc. stock2025 Buyback Activity & Expert Curated Trade Setups - Улправда

Dec 19, 2025

History Review: How Puma Biotechnology Inc. stock reacts to oil pricesWeekly Risk Report & AI Driven Stock Reports - Улправда

Dec 19, 2025

Dec 17, 2025

CRMD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Buy? - TradingView — Track All Markets

Dec 17, 2025

Dec 16, 2025

Why analysts upgrade Puma Biotechnology Inc stock2025 Winners & Losers & Consistent Income Trade Ideas - moha.gov.vn

Dec 16, 2025

Dec 15, 2025

Puma Biotechnology Earnings Notes - Trefis

Dec 15, 2025

Dec 13, 2025

Acorn Capital Advisors LLC Has $14.17 Million Stake in Puma Biotechnology, Inc. $PBYI - MarketBeat

Dec 13, 2025

Dec 09, 2025

With EPS Growth And More, Puma Biotechnology (NASDAQ:PBYI) Makes An Interesting Case - Sahm

Dec 09, 2025

Dec 08, 2025

American Century Companies Inc. Grows Stake in Puma Biotechnology, Inc. $PBYI - MarketBeat

Dec 08, 2025

Dec 06, 2025

What analysts say about Puma Biotechnology Inc stockStock Liquidity Analysis & Minimal Investment Capital Gains - earlytimes.in

Dec 06, 2025

Can Puma Biotechnology Stock Hold Up When Markets Turn? - Trefis

Dec 06, 2025

Dec 04, 2025

What insider trading reveals about Puma Biotechnology Inc. stock2025 Top Gainers & Daily Oversold Bounce Ideas - Newser

Dec 04, 2025

Dec 02, 2025

Puma Biotechnology (NASDAQ:PBYI) Stock Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat

Dec 02, 2025

Nov 30, 2025

With 60% ownership of the shares, Puma Biotechnology, Inc. (NASDAQ:PBYI) is heavily dominated by institutional owners - Yahoo Finance

Nov 30, 2025

Nov 29, 2025